Teresa Shu Ting Chan, NP
Nurse Practitioner · Sunnyvale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Teresa Shu Ting Chan’s office at (408) 739-6000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$20,248
Medicare paid this office $20,248 for 70 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 68 | $18,937 | $96 |
Who their Medicare patients are
70 Original Medicare patients in 2024. Average age 70 · Health risk score 0.72. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 71% · Diabetes 27% · Depression 24% · Coronary heart disease 16%.
The office billed $81,121, Medicare allowed $28,209 and paid $20,248; for 219 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 70 | 219 | 70 | 0.72 | $81,121 | $20,248 |
| 2023 | 68 | 182 | 70 | 0.78 | $68,459 | $17,778 |
| 2022 | 36 | 138 | 69 | 0.89 | $48,447 | $12,805 |
| 2021 | 26 | 68 | 70 | 0.71 | $23,101 | $7,205 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Return visit (30+ min) | 58 | $15,065 | $96 |
| New patient visit (45+ min) | 12 | $1,475 | $123 |
2022: 1 service
| Return visit (30+ min) | 32 | $11,392 | $96 |
2021: 3 services
| Return visit (30+ min) | 16 | $2,999 | $107 |
| Long return visit (40+ min) | 12 | $2,671 | $148 |
| Short return visit (20+ min) | 12 | $1,365 | $76 |
Drugs they prescribed that Part D paid
$243,688
Pharmacies billed $243,688 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 208) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
0 generic and 183 brand-name prescriptions · $243,688 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 86 | $116,343 | $1,353 |
| Wegovy | 42 | $61,687 | $1,469 |
| Mounjaro | 51 | $60,189 | $1,180 |
Year by year
| 2024 | 208 | 42 | 0% (0) | 88% | $243,688 |
| 2023 | 159 | 42 | 0% (0) | 73% | $162,132 |
| 2022 | 114 | 24 | 0% (0) | 78% | $103,020 |
| 2021 | 25 | 14 | 0% (0) | 48% | $11,077 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Ozempic | 82 | $106,143 | $1,294 |
| Mounjaro | 21 | $33,943 | $1,616 |
| Topiramate | 22 | $219 | $10 |
2022: 4 drugs
| Ozempic | 45 | $52,205 | $1,160 |
| Rybelsus | 20 | $22,171 | $1,109 |
| Mounjaro | 13 | $18,050 | $1,388 |
| Topiramate | 20 | $301 | $15 |
Money from drug and device companies
$14 in 2025
| 2025 | 1 | 1 | None | $14 |
| 2024 | 2 | 2 | None | $139 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Takeda Pharmaceuticals U.S.A. | Entyvio | $14 | 1 payment
|
See the published payment
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-03-11 | Entyvio | $14 |
See earlier years (2024)
2024: $139
| Novo Nordisk | Wegovy | $122 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $17 | 1 payment
|
Professional record
- NPI
- 1588253447
- Licence
- CA 95015878
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP2300X (363LP2300X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2021-01-14
- NPI last updated
- 2021-03-23
- NPI record certified
- 2021-03-23
This is when the NPI record was last certified, not a medical board exam.